Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by SeaCrest Wealth Management LLC

SeaCrest Wealth Management LLC grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 24.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,395 shares of the biotechnology company’s stock after buying an additional 273 shares during the period. SeaCrest Wealth Management LLC’s holdings in Axon Enterprise were worth $829,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. DekaBank Deutsche Girozentrale raised its holdings in Axon Enterprise by 32.2% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 22,450 shares of the biotechnology company’s stock valued at $6,689,000 after acquiring an additional 5,464 shares during the last quarter. Envestnet Asset Management Inc. increased its holdings in shares of Axon Enterprise by 12.0% in the second quarter. Envestnet Asset Management Inc. now owns 79,908 shares of the biotechnology company’s stock valued at $23,512,000 after purchasing an additional 8,575 shares during the last quarter. J.W. Cole Advisors Inc. purchased a new position in Axon Enterprise during the second quarter worth approximately $366,000. Dimensional Fund Advisors LP boosted its stake in Axon Enterprise by 10.6% during the second quarter. Dimensional Fund Advisors LP now owns 186,473 shares of the biotechnology company’s stock worth $54,874,000 after buying an additional 17,905 shares during the last quarter. Finally, SYSTM Wealth Solutions LLC grew its holdings in Axon Enterprise by 86.1% in the 2nd quarter. SYSTM Wealth Solutions LLC now owns 3,844 shares of the biotechnology company’s stock valued at $1,131,000 after buying an additional 1,778 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $580.00 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock has a market capitalization of $44.23 billion, a price-to-earnings ratio of 149.87, a price-to-earnings-growth ratio of 14.19 and a beta of 1.04. The business has a 50-day moving average of $612.80 and a 200 day moving average of $454.94. Axon Enterprise, Inc. has a 12 month low of $246.99 and a 12 month high of $698.67.

Insider Activity

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of the stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the sale, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. This represents a 8.77 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the transaction, the insider now owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. This trade represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 50,545 shares of company stock valued at $30,721,337. 6.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

AXON has been the topic of several recent research reports. Northland Securities boosted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. JMP Securities raised their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Robert W. Baird upped their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Finally, TD Cowen initiated coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price for the company. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $504.92.

Check Out Our Latest Research Report on Axon Enterprise

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Stories

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.